Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ILIKANNU'S TRIAL
PACTR202206623958155Not yet recruiting
- Sponsor
- DR ILIKANNU SAMUEL OKWUCHUKWU
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of magnesium sulfate in preeclampsia (2 arms), sponsored by DR ILIKANNU SAMUEL OKWUCHUKWU. Primary endpoint: Occurrence of seizures. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
preeclampsia
Beyond the preview
Go deeper on PACTR202206623958155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202206623958155.